{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:31:18Z","timestamp":1790847078203,"version":"4.1.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0227459","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T18:32:23Z","timestamp":1579026743000},"page":"e0227459","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":25,"title":["Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC)"],"prefix":"10.1371","volume":"15","author":[{"given":"Monika","family":"Pazgan-Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-1094","authenticated-orcid":true,"given":"Micha\u0142","family":"Kukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Zuwa\u0142a-Jagie\u0142\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Derra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Bator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Men\u017cyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7105-6971","authenticated-orcid":true,"given":"Andrzej","family":"Lekstan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Grzebyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"pone.0227459.ref001","first-page":"201","article-title":"Histological classification of liver and intrahepatic bile duct cancers in SEER registries","volume":"38","author":"SF Altekruse","year":"2011","journal-title":"J. Regist. Manag"},{"key":"pone.0227459.ref002","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.14.4300","article-title":"Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis","volume":"14","author":"AI Gomaa","year":"2008","journal-title":"World. J. Gastroenterol"},{"key":"pone.0227459.ref003","doi-asserted-by":"crossref","first-page":"429","DOI":"10.5306\/wjco.v8.i6.429","article-title":"Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"8","author":"A Said","year":"2017","journal-title":"World J. Clin. Oncol"},{"key":"pone.0227459.ref004","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5114\/ceh.2018.75955","article-title":"Underrated enemy\u2013from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract","volume":"4","author":"A Derra","year":"2018","journal-title":"Clin. Exp. Hepatol"},{"key":"pone.0227459.ref005","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4254\/wjh.v9.i11.533","article-title":"Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management","volume":"9","author":"G Cholankeril","year":"2017","journal-title":"World J Hepatol"},{"key":"pone.0227459.ref006","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12072-012-9391-2","article-title":"Angiogenesis: a phenomenon which aggravates chronic liver disease progression","volume":"7","author":"M Kukla","year":"2013","journal-title":"Hepatol Int"},{"key":"pone.0227459.ref007","first-page":"661","article-title":"Chemerin, vaspin and insulin resistance in chronic hepatitis C","volume":"17","author":"M Kukla","year":"2010","journal-title":"J. Viral. Hepat"},{"key":"pone.0227459.ref008","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2119\/molmed.2010.00105","article-title":"Potential role of leptin, adiponectin and three novel adipokines-visfatin, chemerin and vaspin-in chronic hepatitis","volume":"17","author":"M Kukla","year":"2011","journal-title":"Mol. Med"},{"key":"pone.0227459.ref009","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00365520903443852","article-title":"Serum chemerin and vaspin in non-alcoholic fatty liver disease","volume":"45","author":"M Kukla","year":"2010","journal-title":"Scand. J. Gastroenterol"},{"key":"pone.0227459.ref010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.dsx.2012.08.011","article-title":"Visfatin and its role in obesity development","volume":"6","author":"J Stastny","year":"2012","journal-title":"Diabetes Metab. Syndr"},{"key":"pone.0227459.ref011","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4161\/cbt.10.2.12581","article-title":"Nampt\/PBEF\/visfatin and cancer","volume":"10","author":"TQ Bi","year":"2010","journal-title":"Cancer Biol. Ther"},{"key":"pone.0227459.ref012","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cvr\/cvm111","article-title":"Visfatin induces human endothelial VEGF and MMP-2\/9 production via MAPK and PI3K\/Akt signalling pathways: novel insights into visfatin-induced angiogenesis","volume":"78","author":"A Raghu","year":"2008","journal-title":"Cardiovascular Research"},{"key":"pone.0227459.ref013","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.4049\/jimmunol.178.3.1748","article-title":"Visfatin an adipocytokine with proinflammatory and immunomodulating properties","volume":"178","author":"AR Moschen","year":"2007","journal-title":"J. Immunol"},{"key":"pone.0227459.ref014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1515\/hmbci-2014-0037","article-title":"Adipose tissue, obesity and adipokines: role in cancer promotion","volume":"21","author":"A Booth","year":"2015","journal-title":"Horm. Mol. Biol. Clin. Investig"},{"key":"pone.0227459.ref015","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1158\/1940-6207.CAPR-11-0340","article-title":"Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells","volume":"4","author":"S Ninomiya","year":"2011","journal-title":"Cancer Prev. Res. (Phila)."},{"key":"pone.0227459.ref016","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jcla.21491","article-title":"Visfatin levels in nonalcoholic fatty liver disease","volume":"26","author":"E Akbal","year":"2012","journal-title":"J. Clin. Lab. Anal"},{"key":"pone.0227459.ref017","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","article-title":"Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity","volume":"102","author":"K Hida","year":"2005","journal-title":"USA Proc. Natl. Acad. Sci"},{"key":"pone.0227459.ref018","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbrc.2005.11.039","article-title":"Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes","volume":"339","author":"N Kl\u00f6ting","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"pone.0227459.ref019","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","article-title":"Adipokines and insulin resistance","volume":"14","author":"K Rabe","year":"2008","journal-title":"Mol. Med"},{"key":"pone.0227459.ref020","first-page":"213","article-title":"Serum vaspin may be a good indicator of fibrosis in chronic hepatitis C and is not altered by antiviral therapy","volume":"201263","author":"M Kukla","journal-title":"Pol. J. Pathol"},{"key":"pone.0227459.ref021","volume-title":"Physical Status: The Use and Interpretation of Anthropometry: Report of a World Health Organization (WHO) Expert Committee","author":"WHO","year":"1995"},{"key":"pone.0227459.ref022","volume-title":"Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO\/IDF Consultation","author":"World Health Organization","year":"2006"},{"key":"pone.0227459.ref023","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF03346300","article-title":"Increased plasma levels of visfatin\/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome","volume":"30","author":"TD Filippatos","year":"2007","journal-title":"J. Endocrinol. Invest"},{"key":"pone.0227459.ref024","doi-asserted-by":"crossref","first-page":"34833","DOI":"10.1074\/jbc.M805866200","article-title":"Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6\/STAT3 signaling mechanism","volume":"283","author":"Y Li","year":"2008","journal-title":"J. Biol. Chem"},{"key":"pone.0227459.ref025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nm.1906","article-title":"Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner","volume":"15","author":"F Van Gool","year":"2009","journal-title":"Nat. Med"},{"key":"pone.0227459.ref026","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3892\/or.2012.2175","article-title":"Visfatin affects redox adaptative responses and proliferation in Me45 human malignant melanoma cells: an in vitro study","volume":"29","author":"RJ Buldak","year":"2013","journal-title":"Oncol. Rep"},{"key":"pone.0227459.ref027","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cvr\/cvm111","article-title":"Visfatin induces human endothelial VEGF and MMP-2\/9 production via MAPK and PI3K\/Akt signalling pathways: novel insights into visfatin-induced angiogenesis","volume":"78","author":"R Adya","year":"2008","journal-title":"Cardiovasc. Res"},{"key":"pone.0227459.ref028","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cyto.2016.10.007","article-title":"Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection","volume":"90","author":"IT Tsai","year":"2017","journal-title":"Cytokine"},{"key":"pone.0227459.ref029","doi-asserted-by":"crossref","first-page":"23427","DOI":"10.18632\/oncotarget.15080","article-title":"Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma","volume":"8","author":"Y Sun","year":"2017","journal-title":"Oncotarget"},{"key":"pone.0227459.ref030","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"A Fukuhara","year":"2005","journal-title":"Science"},{"key":"pone.0227459.ref031","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/00365513.2014.1003594","article-title":"Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome","volume":"75","author":"M Nourbakhsh","year":"2015","journal-title":"Scand. J. Clin. Lab. Invest"},{"key":"pone.0227459.ref032","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1677\/JME-09-0071","article-title":"Visfatin regulates insulin secretion, insulin receptor signalling and mRNA expression of diabetes-related genes in mouse pancreatic \u03b2-cells","volume":"44","author":"JE Brown","year":"2010","journal-title":"J. Mol. Endocrinol"},{"key":"pone.0227459.ref033","first-page":"481","article-title":"Increased concentration of circulating visfatin associates with post\u2010challenged hyperglycaemia and insulin resistance in IGT subjects","volume":"10","author":"F Kabir","year":"2015","journal-title":"J. Taibah. Univ. Med. Sci"},{"key":"pone.0227459.ref034","doi-asserted-by":"crossref","first-page":"e52346","DOI":"10.1371\/journal.pone.0052346","article-title":"Vaspin Increases Nitric Oxide Bioavailability through the Reduction of Asymmetric Dimethylarginine","volume":"7","author":"CH Jung","year":"2012","journal-title":"Vascular Endothelial Cells. PLoS ONE"},{"key":"pone.0227459.ref035","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.3748\/wjg.v23.i14.2613","article-title":"Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis","volume":"23","author":"M Kukla","year":"2017","journal-title":"World. J. Gastroenterol"},{"key":"pone.0227459.ref036","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cyto.2013.02.012","article-title":"Circulating levels of novel adipocytokines in patients with colorectal cancer","volume":"62","author":"MS Fazeli","year":"2013","journal-title":"Cytokine"},{"key":"pone.0227459.ref037","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2147\/OTT.S155942","article-title":"Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer","volume":"11","author":"A Cymbaluk-P\u0142oska","year":"2018","journal-title":"Onco. Targets Ther"},{"key":"pone.0227459.ref038","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/jc.2007-1853","article-title":"Serum levels of the adipokine vaspin in relation to metabolic and renal parameters","volume":"93","author":"J Seeger","year":"2008","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"pone.0227459.ref039","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","article-title":"Adipokines and insulin resistance","volume":"14","author":"K Rabe","year":"2008","journal-title":"Mol. Med"},{"key":"pone.0227459.ref040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5114\/ceh.2015.51375","article-title":"Insulin resistance and its consequences in chronic hepatitis C","volume":"1","author":"M Kukla","year":"2015","journal-title":"Clin. Exp. Hepatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T03:31:26Z","timestamp":1722310286000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0227459"}},"subtitle":[],"editor":[{"given":"Matias A.","family":"Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0227459","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]}}}